Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.25 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.95.
Market Cap
9.25T
Revenue
4.67T
Profits
189.08B
PE Ratio
48.95
Profit Margin
4.05%
Dividend Yield
0.38%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | 1.47% | 948,156 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 653.46B | 0.43% | 1,577,355 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 467.95B | 0.32% | 1,216,995 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 367.95B | 1.55% | 2,322,170 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 338.73B | 0.12% | 1,848,566 | 450.53B |
| 6 | NVS | Novartis AG | 265.70B | 0.90% | 808,650 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 259.31B | 1.52% | 1,718,662 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 242.17B | 0.54% | 770,530 | 46.34B |
| 9 | AMGN | Amgen Inc. | 212.16B | 1.76% | 864,223 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 191.02B | -8.14% | 35,029,221 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 187.65B | 0.82% | 2,266,612 | 30.46B |
| 12 | ABT | Abbott Laboratories | 177.80B | 0.14% | 1,779,304 | 46.59B |
| 13 | PFE | Pfizer Inc. | 157.99B | 0.22% | 14,192,162 | 63.70B |
| 14 | DHR | Danaher Corporation | 150.31B | 0.94% | 1,026,016 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.10B | 1.54% | 1,101,741 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 129.89B | 0.81% | 343,265 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.61B | -0.16% | 2,272,051 | 49.19B |
| 18 | MDT | Medtronic plc | 117.80B | -0.04% | 2,765,702 | 37.54B |
| 19 | CVS | CVS Health Corporation | 112.00B | -1.43% | 2,913,461 | 412.65B |
| 20 | SYK | Stryker Corporation | 105.01B | -0.49% | 1,131,667 | 25.84B |
| 21 | MCK | McKesson Corporation | 103.71B | 1.70% | 213,645 | 410.98B |
| 22 | SNY | Sanofi | 102.49B | 0.49% | 1,288,378 | 55.89B |
| 23 | GSK | GSK plc | 102.39B | 1.87% | 1,528,856 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 93.05B | 0.49% | 496,333 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 88.42B | -0.79% | 317,582 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.01B | 2.09% | 269,724 | 15.53B |
| 27 | CI | The Cigna Group | 72.56B | -0.24% | 338,537 | 282.38B |
| 28 | MRNA | Moderna, Inc. | 67.45B | 9.68% | 10,672,940 | 2.23B |
| 29 | BSX | Boston Scientific Corporation | 62.69B | -0.18% | 7,418,859 | 21.00B |
| 30 | ARGX | argenx SE | 62.49B | 0.69% | 122,580 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.71B | -0.05% | 869,245 | 28.42B |
| 32 | COR | Cencora, Inc. | 59.94B | 1.73% | 267,783 | 332.77B |
| 33 | NTRA | Natera, Inc. | 53.03B | -0.41% | 663,953 | 2.71B |
| 34 | CAH | Cardinal Health, Inc. | 52.66B | 0.47% | 284,331 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 51.03B | 0.32% | 1,205,273 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.15B | -0.27% | 392,266 | 22.48B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 46.88B | 3.21% | 2,349,125 | 17.32B |
| 38 | A | Agilent Technologies, Inc. | 45.65B | 3.48% | 794,901 | 7.37B |
| 39 | HUM | Humana Inc. | 45.43B | -2.05% | 233,029 | 145.68B |
| 40 | IQV | IQVIA Holdings Inc. | 44.04B | 0.44% | 776,010 | 16.98B |
| 41 | VEEV | Veeva Systems Inc. | 42.04B | -0.20% | 453,876 | 3.46B |
| 42 | MDLN | Medline Inc. | 41.96B | 0.87% | 3,538,753 | 29.94B |
| 43 | WAT | Waters Corporation | 41.54B | 0.29% | 324,247 | 4.64B |
| 44 | ONC | BeOne Medicines AG | 41.46B | 3.93% | 263,357 | 6.13B |
| 45 | RVMD | Revolution Medicines, Inc. | 41.21B | 0.70% | 945,293 | - |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.71B | 0.99% | 197,078 | 4.55B |
| 47 | HLN | Haleon plc | 40.14B | 0.75% | 25,227,954 | 14.80B |
| 48 | ILMN | Illumina, Inc. | 36.46B | 0.78% | 1,294,082 | 4.49B |
| 49 | RPRX | Royalty Pharma plc | 33.76B | 0.51% | 1,394,571 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 33.51B | -0.62% | 1,190,454 | 4.97B |
| 51 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.96B | 2.83% | 448,589 | 4.80B |
| 52 | BIIB | Biogen Inc. | 32.66B | 2.56% | 306,779 | 10.03B |
| 53 | RMD | ResMed Inc. | 32.33B | 0.45% | 264,599 | 5.65B |
| 54 | CNC | Centene Corporation | 32.08B | -0.25% | 1,754,592 | 180.30B |
| 55 | ALC | Alcon Inc. | 31.50B | 0.24% | 547,249 | 10.86B |
| 56 | ZTS | Zoetis Inc. | 29.60B | 0.31% | 1,894,283 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 29.10B | 0.47% | 1,084,105 | 21.27B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.56B | 2.38% | 64,052 | 4.13B |
| 59 | ROIV | Roivant Sciences Ltd. | 28.08B | -2.24% | 2,462,987 | 7.53M |
| 60 | DGX | Quest Diagnostics Incorporated | 27.05B | -0.54% | 269,874 | 11.56B |
| 61 | INSM | Insmed Incorporated | 26.78B | 2.20% | 899,882 | 1.14B |
| 62 | LH | Labcorp Holdings Inc. | 26.12B | 0.43% | 146,873 | 14.35B |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.62B | 0.49% | 146,401 | 3.33B |
| 64 | INCY | Incyte Corporation | 25.36B | -0.17% | 513,196 | 5.82B |
| 65 | BNTX | BioNTech SE | 24.48B | 1.44% | 326,065 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 24.21B | 1.15% | 282,990 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 23.36B | -2.98% | 1,119,955 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.22B | - | 126,605 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.14B | 0.21% | 229,772 | 21.81B |
| 70 | GMAB | Genmab A/S | 20.72B | -0.20% | 887,698 | 4.13B |
| 71 | STE | STERIS plc | 20.03B | 0.20% | 228,665 | 6.04B |
| 72 | VTRS | Viatris Inc. | 19.80B | 1.71% | 1,834,230 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.02B | -0.93% | 389,091 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.40B | 1.79% | 76,554 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.01B | -0.01% | 735,305 | 2.91B |
| 76 | ASND | Ascendis Pharma A/S | 15.70B | 0.96% | 235,525 | 1.20B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.66B | 0.23% | 146,230 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.19B | 0.43% | 182,514 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.63B | -1.58% | 541,300 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.13B | -2.31% | 792,692 | 2.44B |
| 81 | TEM | Tempus AI, Inc. | 14.03B | -0.09% | 3,829,318 | 1.43B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.43B | -5.71% | 3,019,242 | - |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.27B | -0.01% | 252,064 | 4.00B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 12.95B | -0.56% | 1,751,534 | 713.07M |
| 85 | ICLR | ICON Public Limited Company | 12.88B | 1.70% | 484,401 | 8.29B |
| 86 | HALO | Halozyme Therapeutics, Inc. | 12.61B | -1.18% | 1,663,908 | 1.66B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.58B | 5.54% | 417,632 | 830.81M |
| 88 | PEN | Penumbra, Inc. | 12.52B | 0.07% | 138,650 | 1.50B |
| 89 | BMRN | BioMarin Pharmaceutical Inc. | 12.41B | 0.27% | 696,178 | 3.41B |
| 90 | EHC | Encompass Health Corporation | 12.10B | 0.77% | 253,065 | 6.21B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.96B | -2.60% | 77,305 | 1.28B |
| 92 | BAX | Baxter International Inc. | 11.83B | 0.39% | 5,626,435 | 11.47B |
| 93 | FMS | Fresenius Medical Care AG | 11.76B | 0.38% | 345,521 | 22.19B |
| 94 | BTSG | BrightSpring Health Services, Inc. | 11.70B | -1.06% | 723,795 | 14.37B |
| 95 | DVA | DaVita Inc. | 11.69B | -0.32% | 179,659 | 14.01B |
| 96 | SNN | Smith & Nephew plc | 11.56B | 0.51% | 762,947 | 6.30B |
| 97 | TECH | Bio-Techne Corporation | 11.37B | 0.17% | 1,744,929 | 1.22B |
| 98 | ELAN | Elanco Animal Health Incorporated | 11.22B | 0.13% | 1,524,673 | 5.02B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 10.71B | -1.62% | 174,910 | 776.57M |
| 100 | ALGN | Align Technology, Inc. | 10.46B | -0.27% | 433,422 | 4.14B |
| 101 | COO | The Cooper Companies, Inc. | 10.41B | -0.98% | 1,369,772 | 4.24B |
| 102 | UHS | Universal Health Services, Inc. | 10.37B | -0.41% | 300,638 | 18.11B |
| 103 | MOH | Molina Healthcare, Inc. | 10.30B | -1.52% | 142,758 | 42.47B |
| 104 | AVTR | Avantor, Inc. | 10.24B | -2.42% | 3,129,825 | 6.56B |
| 105 | TXG | 10x Genomics, Inc. | 10.19B | 2.08% | 1,107,606 | 616.91M |
| 106 | RGEN | Repligen Corporation | 10.17B | 1.91% | 391,584 | 785.10M |
| 107 | RDY | Dr. Reddy's Laboratories Limited | 10.17B | 2.01% | 1,052,558 | 3.50B |
| 108 | TWST | Twist Bioscience Corporation | 10.11B | -3.45% | 1,230,462 | 431.80M |
| 109 | ENSG | The Ensign Group, Inc. | 10.10B | 0.45% | 78,475 | 5.49B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.01B | -0.53% | 64,263 | 2.59B |
| 111 | GMED | Globus Medical, Inc. | 9.96B | 0.11% | 445,370 | 3.14B |
| 112 | KRYS | Krystal Biotech, Inc. | 9.89B | -0.76% | 69,852 | 440.48M |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.81B | 0.23% | 220,998 | 105.00M |
| 114 | PODD | Insulet Corporation | 9.72B | -0.28% | 446,893 | 3.05B |
| 115 | OSCR | Oscar Health, Inc. | 9.67B | -2.40% | 4,560,337 | 15.32B |
| 116 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.55B | 1.73% | 1,212,309 | 669.50M |
| 117 | GKOS | Glaukos Corporation | 9.53B | -1.29% | 264,118 | 612.84M |
| 118 | HSIC | Henry Schein, Inc. | 9.50B | 0.52% | 617,216 | 13.60B |
| 119 | BRKR | Bruker Corporation | 9.44B | 1.01% | 603,303 | 3.50B |
| 120 | CYTK | Cytokinetics, Incorporated | 9.39B | -1.79% | 515,435 | 67.67M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.30B | 0.50% | 175,464 | 281.99M |
| 122 | QGEN | Qiagen N.V. | 9.21B | 2.75% | 704,689 | 2.10B |
| 123 | ABVX | ABIVAX Société Anonyme | 9.10B | -1.86% | 466,855 | 5.67M |
| 124 | IBRX | ImmunityBio, Inc. | 8.87B | -1.30% | 6,608,834 | 165.79M |
| 125 | PCVX | Vaxcyte, Inc. | 8.81B | 1.89% | 416,049 | - |
| 126 | CAI | Caris Life Sciences, Inc. | 8.54B | 0.77% | 1,977,803 | 989.61M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.28B | -0.82% | 246,604 | 7.46M |
| 128 | TGTX | TG Therapeutics, Inc. | 8.13B | 0.84% | 1,234,202 | 799.54M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 8.03B | 0.95% | 339,164 | - |
| 130 | ATR | AptarGroup, Inc. | 7.94B | 0.41% | 115,649 | 3.93B |
| 131 | HQY | HealthEquity, Inc. | 7.83B | -0.49% | 161,318 | 1.36B |
| 132 | IMVT | Immunovant, Inc. | 7.62B | -0.11% | 292,622 | - |
| 133 | HNGE | Hinge Health, Inc. | 7.54B | -1.51% | 461,104 | 720.06M |
| 134 | IONS | Ionis Pharmaceuticals, Inc. | 7.51B | 1.71% | 2,466,718 | 874.09M |
| 135 | ALKS | Alkermes plc | 7.37B | 1.27% | 1,690,283 | 1.67B |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 7.20B | 10.42% | 3,272,448 | 3.12B |
| 137 | BLTE | Belite Bio, Inc | 6.91B | 0.37% | 65,167 | - |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.81B | 1.27% | 225,551 | 239.92M |
| 139 | CGON | CG Oncology, Inc. | 6.76B | 2.16% | 319,955 | 6.23M |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.69B | 2.47% | 4,204,441 | 2.58B |
| 141 | PACS | PACS Group, Inc. | 6.67B | 0.07% | 215,988 | 5.55B |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.55B | -0.17% | 386,501 | 1.56B |
| 143 | GRFS | Grifols, S.A. | 6.52B | 0.41% | 225,650 | 8.48B |
| 144 | CHE | Chemed Corporation | 6.48B | -1.28% | 40,305 | 2.60B |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.13B | -2.54% | 570,777 | - |
| 146 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.12B | 1.52% | 146,784 | 840.85M |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.02B | 0.88% | 222,270 | 618.07M |
| 148 | BLCO | Bausch + Lomb Corporation | 6.00B | -0.36% | 146,627 | 5.32B |
| 149 | MMED | MiniMed Group, Inc. | 5.99B | -2.29% | 810,676 | 3.22B |
| 150 | LQDA | Liquidia Corporation | 5.91B | -1.20% | 271,856 | 450.91M |
| 151 | STVN | Stevanato Group S.p.A. | 5.91B | -0.23% | 295,142 | 1.40B |
| 152 | TVTX | Travere Therapeutics, Inc. | 5.91B | -0.06% | 491,056 | 591.33M |
| 153 | SRRK | Scholar Rock Holding Corporation | 5.82B | 2.47% | 1,213,309 | - |
| 154 | RDNT | RadNet, Inc. | 5.82B | -2.68% | 202,190 | 2.27B |
| 155 | LGND | Ligand Pharmaceuticals Incorporated | 5.73B | 1.42% | 55,561 | 290.54M |
| 156 | CRSP | CRISPR Therapeutics AG | 5.65B | 3.32% | 920,788 | 13.39M |
| 157 | COGT | Cogent Biosciences, Inc. | 5.57B | 1.81% | 1,611,525 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.47B | 0.21% | 270,698 | 1.01B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.46B | 0.76% | 293,935 | 1.90M |
| 160 | TFX | Teleflex Incorporated | 5.32B | 0.85% | 224,035 | 2.25B |
| 161 | SHC | Sotera Health Company | 5.32B | -0.53% | 416,448 | 1.22B |
| 162 | ERAS | Erasca, Inc. | 5.29B | 2.37% | 950,389 | - |
| 163 | DFTX | Definium Therapeutics, Inc. | 5.23B | 0.33% | 965,892 | - |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.10B | -0.05% | 108,349 | 1.58B |
| 165 | BLLN | BillionToOne, Inc. | 4.92B | -1.46% | 207,432 | 397.41M |
| 166 | HAE | Haemonetics Corporation | 4.92B | -0.18% | 120,508 | 1.35B |
| 167 | WAY | Waystar Holding Corp. | 4.89B | -0.55% | 675,898 | 1.21B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.83B | -1.90% | 597,205 | - |
| 169 | LFST | LifeStance Health Group, Inc. | 4.81B | 0.08% | 1,273,192 | 1.58B |
| 170 | GRAL | GRAIL, Inc. | 4.76B | 31.94% | 2,326,110 | 165.26M |
| 171 | DOCS | Doximity, Inc. | 4.73B | 1.57% | 974,473 | 655.57M |
| 172 | ACAD | ACADIA Pharmaceuticals Inc. | 4.64B | -1.43% | 449,583 | 1.14B |
| 173 | IOVA | Iovance Biotherapeutics, Inc. | 4.61B | -0.78% | 6,287,606 | 324.97M |
| 174 | MANE | Veradermics, Incorporated | 4.55B | 1.95% | 189,984 | - |
| 175 | ADPT | Adaptive Biotechnologies Corporation | 4.44B | -2.66% | 652,386 | 308.08M |
| 176 | CON | Concentra Group Holdings Parent, Inc. | 4.43B | -2.14% | 248,934 | 2.29B |
| 177 | PBLS | Parabilis Medicines, Inc. | 4.40B | -14.67% | 722,797 | 148.00K |
| 178 | HTFL | HeartFlow, Inc. | 4.37B | -1.02% | 582,707 | 212.07M |
| 179 | ITGR | Integer Holdings Corporation | 4.30B | 0.11% | 132,270 | 1.84B |
| 180 | LIVN | LivaNova PLC | 4.25B | -1.22% | 152,501 | 1.47B |
| 181 | INDV | Indivior Pharmaceuticals, Inc. | 4.18B | 1.53% | 333,926 | 1.33B |
| 182 | ABCL | AbCellera Biologics Inc. | 4.08B | -0.36% | 2,738,593 | 66.17M |
| 183 | CELC | Celcuity Inc. | 4.07B | 3.19% | 343,138 | - |
| 184 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.01B | -1.33% | 322,979 | -665.00K |
| 185 | RLAY | Relay Therapeutics, Inc. | 3.99B | -3.26% | 990,257 | 10.35M |
| 186 | ICUI | ICU Medical, Inc. | 3.88B | 1.74% | 64,570 | 2.16B |
| 187 | TLX | Telix Pharmaceuticals Limited | 3.81B | -10.44% | 625,859 | 890.79M |
| 188 | TNGX | Tango Therapeutics, Inc. | 3.80B | 3.54% | 1,380,990 | 53.81M |
| 189 | XENE | Xenon Pharmaceuticals Inc. | 3.77B | -1.94% | 2,437,587 | 7.50M |
| 190 | NVST | Envista Holdings Corporation | 3.76B | 0.21% | 972,235 | 2.86B |
| 191 | IDYA | IDEAYA Biosciences, Inc. | 3.70B | -0.05% | 148,952 | 234.13M |
| 192 | PLSE | Pulse Biosciences, Inc. | 3.70B | -3.73% | 168,294 | 1.19M |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.66B | 1.49% | 170,388 | 825.34M |
| 194 | OGN | Organon & Co. | 3.61B | 0.55% | 1,071,542 | 6.13B |
| 195 | OPCH | Option Care Health, Inc. | 3.60B | -1.07% | 911,803 | 5.69B |
| 196 | ELVN | Enliven Therapeutics, Inc. | 3.54B | -2.35% | 222,699 | - |
| 197 | LEGN | Legend Biotech Corporation | 3.52B | 3.29% | 1,425,800 | 1.27B |
| 198 | NHC | National HealthCare Corporation | 3.49B | 0.33% | 61,962 | 1.56B |
| 199 | TARS | Tarsus Pharmaceuticals, Inc. | 3.39B | -1.19% | 92,635 | 606.33M |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.35B | -1.07% | 1,475,170 | - |
| 201 | VCYT | Veracyte, Inc. | 3.32B | 3.66% | 638,683 | 561.90M |
| 202 | RCUS | Arcus Biosciences, Inc. | 3.24B | 0.83% | 347,849 | 117.00M |
| 203 | DYN | Dyne Therapeutics, Inc. | 3.24B | 1.40% | 1,184,440 | - |
| 204 | DNLI | Denali Therapeutics Inc. | 3.19B | 1.27% | 973,497 | 3.60M |
| 205 | ARQT | Arcutis Biotherapeutics, Inc. | 3.17B | -0.57% | 587,889 | 463.98M |
| 206 | TMDX | TransMedics Group, Inc. | 3.06B | 2.24% | 217,434 | 668.47M |
| 207 | QURE | uniQure N.V. | 3.05B | 0.09% | 398,922 | 18.67M |
| 208 | CLDX | Celldex Therapeutics, Inc. | 2.97B | -1.23% | 187,791 | 158.00K |
| 209 | RGC | Regencell Bioscience Holdings Limited | 2.96B | 3.28% | 45,554 | - |
| 210 | AVAH | Aveanna Healthcare Holdings Inc. | 2.94B | -1.35% | 816,012 | 2.60B |
| 211 | ZLAB | Zai Lab Limited | 2.94B | 1.87% | 491,700 | 449.61M |
| 212 | WRBY | Warby Parker Inc. | 2.93B | 5.51% | 1,951,442 | 911.61M |
| 213 | MBX | MBX Biosciences, Inc. | 2.92B | -3.67% | 376,753 | - |
| 214 | WGS | GeneDx Holdings Corp. | 2.92B | -3.23% | 274,356 | 454.43M |
| 215 | ATRC | AtriCure, Inc. | 2.91B | -1.55% | 354,653 | 569.62M |
| 216 | NEOG | Neogen Corporation | 2.89B | 2.04% | 1,806,720 | 870.40M |
| 217 | IMNM | Immunome, Inc. | 2.77B | 1.92% | 593,430 | 4.02M |
| 218 | CDNA | CareDx, Inc. | 2.77B | -0.50% | 268,098 | 458.09M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.76B | -3.07% | 209,935 | 1.46B |
| 220 | PGEN | Precigen, Inc. | 2.75B | -1.29% | 1,527,406 | 85.72M |
| 221 | BKD | Brookdale Senior Living Inc. | 2.72B | -0.57% | 975,910 | 2.93B |
| 222 | ACHC | Acadia Healthcare Company, Inc. | 2.71B | 2.68% | 477,996 | 3.37B |
| 223 | AXGN | Axogen, Inc. | 2.68B | 3.13% | 553,255 | 251.17M |
| 224 | IRON | Disc Medicine, Inc. | 2.62B | -1.68% | 151,530 | - |
| 225 | NAMS | NewAmsterdam Pharma Company N.V. | 2.62B | -2.42% | 2,921,476 | 7.12M |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.62B | -0.79% | 513,303 | 36.77M |
| 227 | PHVS | Pharvaris N.V. | 2.57B | 0.52% | 331,542 | - |
| 228 | GPCR | Structure Therapeutics Inc. | 2.53B | 1.40% | 346,072 | - |
| 229 | HCM | HUTCHMED (China) Limited | 2.52B | 5.34% | 49,237 | 549.12M |
| 230 | BEAM | Beam Therapeutics Inc. | 2.50B | 0.36% | 1,009,637 | 156.04M |
| 231 | MLYS | Mineralys Therapeutics, Inc. | 2.50B | 0.75% | 333,485 | - |
| 232 | PRVA | Privia Health Group, Inc. | 2.49B | -1.81% | 372,120 | 2.36B |
| 233 | NEO | NeoGenomics, Inc. | 2.48B | -3.01% | 615,033 | 766.30M |
| 234 | VERA | Vera Therapeutics, Inc. | 2.47B | 1.00% | 603,168 | - |
| 235 | VRDN | Viridian Therapeutics, Inc. | 2.47B | -0.77% | 653,061 | 71.13M |
| 236 | SUPN | Supernus Pharmaceuticals, Inc. | 2.47B | 1.17% | 355,155 | 830.44M |
| 237 | HRMY | Harmony Biosciences Holdings, Inc. | 2.43B | -0.88% | 240,396 | 959.90M |
| 238 | ALMR | Alamar Biosciences, Inc. | 2.41B | -0.17% | 244,986 | 100.42M |
| 239 | CLOV | Clover Health Investments, Corp. | 2.39B | 0.90% | 1,495,497 | 2.48B |
| 240 | NKTR | Nektar Therapeutics | 2.31B | 0.70% | 415,065 | 54.59M |
| 241 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -1.39% | 3,182,876 | - |
| 242 | SDGR | Schrödinger, Inc. | 2.27B | 4.72% | 1,406,062 | 259.04M |
| 243 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.24B | 0.81% | 1,122,415 | 940.61M |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | -1.42% | 245,759 | 311.51M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | 3.95% | 225,158 | 1.10B |
| 246 | GENB | Generate Biomedicines, Inc. | 2.20B | 0.12% | 592,891 | 26.48M |
| 247 | TRLV | Trulieve Cannabis Corp. | 2.20B | 3.07% | 799,805 | 1.14B |
| 248 | PVLA | Palvella Therapeutics, Inc. | 2.19B | 1.00% | 37,548 | - |
| 249 | INSP | Inspire Medical Systems, Inc. | 2.17B | -2.31% | 368,682 | 898.74M |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.17B | -1.20% | 738,299 | 52.06M |
| 251 | UFPT | UFP Technologies, Inc. | 2.15B | 0.26% | 59,351 | 631.64M |
| 252 | BFLY | Butterfly Network, Inc. | 2.14B | 2.03% | 1,950,528 | 112.14M |
| 253 | ADUS | Addus HomeCare Corporation | 2.12B | -0.79% | 58,450 | 1.48B |
| 254 | SRPT | Sarepta Therapeutics, Inc. | 2.11B | -0.45% | 512,643 | 1.97B |
| 255 | URGN | UroGen Pharma Ltd. | 2.11B | -0.05% | 147,201 | 188.73M |
| 256 | ZBIO | Zenas BioPharma, Inc. | 2.10B | 2.41% | 146,817 | 1.00M |
| 257 | RXRX | Recursion Pharmaceuticals, Inc. | 2.10B | 2.35% | 17,003,890 | 54.86M |
| 258 | ADMA | ADMA Biologics, Inc. | 2.10B | 2.85% | 904,443 | 512.28M |
| 259 | BHVN | Biohaven Ltd. | 2.10B | 1.98% | 1,883,657 | - |
| 260 | BHC | Bausch Health Companies Inc. | 2.10B | -1.15% | 580,702 | 10.85B |
| 261 | NUVB | Nuvation Bio Inc. | 2.10B | 2.05% | 1,520,814 | 169.90M |
| 262 | ALVO | Alvotech | 2.09B | -0.34% | 942,602 | 494.61M |
| 263 | TRVI | Trevi Therapeutics, Inc. | 2.08B | -2.21% | 410,190 | - |
| 264 | CMPS | COMPASS Pathways plc | 2.07B | -1.65% | 1,350,567 | - |
| 265 | PGNY | Progyny, Inc. | 2.05B | -1.66% | 254,688 | 1.31B |
| 266 | MD | Pediatrix Medical Group, Inc. | 2.04B | -0.96% | 164,184 | 1.95B |
| 267 | ESTA | Establishment Labs Holdings Inc. | 2.04B | -1.40% | 77,325 | 245.82M |
| 268 | KOD | Kodiak Sciences Inc. | 2.02B | -1.53% | 270,086 | - |
| 269 | VCEL | Vericel Corporation | 2.01B | -1.72% | 164,782 | 306.30M |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 1.48% | 311,186 | 98.34M |
| 271 | MESO | Mesoblast Limited | 1.97B | 1.55% | 70,608 | 120.25M |
| 272 | PRGO | Perrigo Company plc | 1.95B | 3.83% | 698,304 | 4.14B |
| 273 | NVCR | NovoCure Limited | 1.93B | -0.84% | 157,009 | 699.19M |
| 274 | GHRS | GH Research PLC | 1.92B | -0.85% | 53,312 | - |
| 275 | XRAY | DENTSPLY SIRONA Inc. | 1.89B | -0.52% | 2,228,848 | 3.64B |
| 276 | RAPP | Rapport Therapeutics, Inc. | 1.88B | -2.92% | 320,365 | 20.00M |
| 277 | FTRE | Fortrea Holdings Inc. | 1.88B | -0.70% | 347,027 | 2.68B |
| 278 | ZYME | Zymeworks Inc. | 1.87B | -0.64% | 135,240 | 37.13M |
| 279 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 3.12% | 102,717 | 1.13B |
| 280 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.85B | 2.08% | 842,039 | 208.78M |
| 281 | XNCR | Xencor, Inc. | 1.85B | 0.49% | 473,920 | 104.97M |
| 282 | BLFS | BioLife Solutions, Inc. | 1.82B | 1.17% | 131,470 | 106.69M |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.82B | 0.13% | 78,873 | 481.07M |
| 284 | FRNM | Freenome, Inc. | 1.81B | -1.46% | 291,118 | 35.41M |
| 285 | VIR | Vir Biotechnology, Inc. | 1.81B | 0.94% | 458,587 | 303.23M |
| 286 | LMAT | LeMaitre Vascular, Inc. | 1.81B | 0.14% | 53,029 | 262.43M |
| 287 | SEPN | Septerna, Inc. | 1.81B | -0.03% | 95,702 | 98.88M |
| 288 | STOK | Stoke Therapeutics, Inc. | 1.80B | -1.83% | 266,918 | 27.59M |
| 289 | COAG | Hemab Therapeutics Holdings, Inc. | 1.79B | -6.82% | 183,970 | - |
| 290 | SGRY | Surgery Partners, Inc. | 1.77B | 2.72% | 850,884 | 3.37B |
| 291 | TYRA | Tyra Biosciences, Inc. | 1.76B | -0.39% | 491,189 | - |
| 292 | NBTX | Nanobiotix S.A. | 1.73B | 3.46% | 72,959 | 38.27M |
| 293 | PSNL | Personalis, Inc. | 1.72B | -1.71% | 757,865 | 69.67M |
| 294 | NVAX | Novavax, Inc. | 1.72B | 2.87% | 2,341,955 | 413.80M |
| 295 | NTLA | Intellia Therapeutics, Inc. | 1.71B | 0.62% | 2,167,784 | 59.51M |
| 296 | ANIP | ANI Pharmaceuticals, Inc. | 1.69B | 3.41% | 228,092 | 978.38M |
| 297 | ALHC | Alignment Healthcare, Inc. | 1.68B | -2.99% | 5,287,954 | 4.58B |
| 298 | ABSI | Absci Corporation | 1.67B | 0.83% | 1,802,589 | 1.56M |
| 299 | IMCR | Immunocore Holdings plc | 1.67B | 1.09% | 133,011 | 430.78M |
| 300 | ASTH | Astrana Health, Inc. | 1.66B | -5.59% | 244,159 | 3.84B |
| 301 | ANAB | AnaptysBio, Inc. | 1.64B | 0.11% | 134,425 | 232.39M |
| 302 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | - | 668,948 | 5.49M |
| 303 | INBX | Inhibrx Biosciences, Inc. | 1.63B | 1.33% | 113,675 | 1.30M |
| 304 | BRVE | Braveheart Bio, Inc. | 1.63B | -13.08% | 559,249 | - |
| 305 | ETON | Eton Pharmaceuticals, Inc. | 1.60B | 0.77% | 118,404 | 105.60M |
| 306 | SNDX | Syndax Pharmaceuticals, Inc. | 1.60B | 1.59% | 889,736 | 252.25M |
| 307 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | 6.34% | 787,197 | 335.41M |
| 308 | ATEC | Alphatec Holdings, Inc. | 1.57B | -0.10% | 720,229 | 815.05M |
| 309 | KLRA | Kailera Therapeutics, Inc. | 1.57B | -5.61% | 348,071 | - |
| 310 | KRSA | Korsana Biosciences, Inc. | 1.54B | -3.57% | 9,992 | - |
| 311 | INVA | Innoviva, Inc. | 1.53B | 0.09% | 212,451 | 440.00M |
| 312 | KARD | Kardigan, Inc. | 1.51B | -2.76% | 224,934 | - |
| 313 | AAPG | Ascentage Pharma Group International | 1.49B | 5.05% | 9,455 | 94.61M |
| 314 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 4.27% | 341,373 | - |
| 315 | ARDT | Ardent Health, Inc. | 1.48B | 0.38% | 183,961 | 6.41B |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.48B | 0.28% | 169,189 | 1.86B |
| 317 | OMCL | Omnicell, Inc. | 1.47B | -0.19% | 125,429 | 1.25B |
| 318 | BCAX | Bicara Therapeutics Inc. | 1.47B | -2.08% | 117,218 | - |
| 319 | AZTA | Azenta, Inc. | 1.47B | 0.66% | 216,874 | 613.81M |
| 320 | AGL | agilon health, inc. | 1.46B | -2.27% | 175,900 | 5.92B |
| 321 | KMTS | Kestra Medical Technologies, Ltd. | 1.46B | - | 41,807 | 106.73M |
| 322 | RARE | Ultragenyx Pharmaceutical Inc. | 1.45B | 1.45% | 2,782,951 | 717.00M |
| 323 | INNV | InnovAge Holding Corp. | 1.44B | -3.30% | 106,197 | 989.71M |
| 324 | LTGO | Latigo Biotherapeutics, Inc. | 1.43B | -4.21% | 115,482 | - |
| 325 | PAHC | Phibro Animal Health Corporation | 1.43B | 1.79% | 50,373 | 1.52B |
| 326 | DRTS | Alpha Tau Medical Ltd. | 1.41B | -0.07% | 206,991 | - |
| 327 | AVLN | Avalyn Pharma Inc. | 1.40B | 0.06% | 90,277 | - |
| 328 | NUTX | Nutex Health Inc. | 1.40B | -2.24% | 60,284 | 846.72M |
| 329 | DMRA | Damora Therapeutics, Inc. | 1.39B | -0.31% | 305,388 | - |
| 330 | TRAX | First Tracks Biotherapeutics, Inc. | 1.38B | -0.13% | 287,487 | - |
| 331 | SVRA | Savara Inc. | 1.37B | 0.47% | 417,323 | - |
| 332 | LBRX | LB Pharmaceuticals Inc | 1.37B | -0.34% | 111,517 | - |
| 333 | PNTG | The Pennant Group, Inc. | 1.36B | -1.77% | 77,021 | 1.10B |
| 334 | CGEM | Cullinan Therapeutics, Inc. | 1.36B | 0.19% | 363,186 | - |
| 335 | CNMD | CONMED Corporation | 1.35B | -1.03% | 76,103 | 1.37B |
| 336 | OMER | Omeros Corporation | 1.33B | 2.63% | 387,790 | 38.42M |
| 337 | AMN | AMN Healthcare Services, Inc. | 1.32B | -0.70% | 129,829 | 3.43B |
| 338 | ORIC | ORIC Pharmaceuticals, Inc. | 1.30B | -1.56% | 293,128 | - |
| 339 | CERT | Certara, Inc. | 1.29B | 0.65% | 549,982 | 421.75M |
| 340 | HROW | Harrow, Inc. | 1.28B | 3.17% | 213,052 | 275.59M |
| 341 | VOR | Vor Biopharma Inc. | 1.27B | 0.33% | 977,203 | - |
| 342 | MGTX | MeiraGTx Holdings plc | 1.24B | -2.45% | 602,173 | 397.50M |
| 343 | OPK | OPKO Health, Inc. | 1.24B | -0.60% | 759,572 | 587.90M |
| 344 | OMDA | Omada Health, Inc. | 1.23B | -1.27% | 278,255 | 309.76M |
| 345 | USPH | U.S. Physical Therapy, Inc. | 1.23B | -0.17% | 79,334 | 804.27M |
| 346 | CRON | Cronos Group Inc. | 1.23B | -1.04% | 265,255 | 179.09M |
| 347 | MAZE | Maze Therapeutics, Inc. | 1.22B | -2.31% | 186,344 | 20.00M |
| 348 | TNDM | Tandem Diabetes Care, Inc. | 1.21B | 3.08% | 497,190 | 1.04B |
| 349 | REPL | Replimune Group, Inc. | 1.21B | -2.07% | 584,976 | - |
| 350 | AKTS | Aktis Oncology, Inc. | 1.20B | -1.55% | 269,927 | 10.06M |
| 351 | IMTX | Immatics N.V. | 1.19B | 0.87% | 146,092 | 47.65M |
| 352 | IART | Integra LifeSciences Holdings Corporation | 1.19B | 0.39% | 328,767 | 1.65B |
| 353 | ANRO | Alto Neuroscience, Inc. | 1.18B | -0.79% | 108,318 | - |
| 354 | GDRX | GoodRx Holdings, Inc. | 1.15B | 0.15% | 201,107 | 785.23M |
| 355 | MNKD | MannKind Corporation | 1.15B | 1.27% | 1,164,064 | 393.63M |
| 356 | BBNX | Beta Bionics, Inc. | 1.15B | -0.05% | 325,876 | 119.01M |
| 357 | AORT | Artivion, Inc. | 1.14B | 0.30% | 193,494 | 471.47M |
| 358 | TDOC | Teladoc Health, Inc. | 1.14B | -0.63% | 1,145,296 | 2.49B |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.13B | -0.89% | 88,445 | - |
| 360 | BVS | Bioventus Inc. | 1.12B | 2.79% | 219,434 | 581.85M |
| 361 | ODTX | Odyssey Therapeutics, Inc. | 1.11B | -5.02% | 116,027 | 99.00K |
| 362 | OBX | Obsidian Therapeutics, Inc. | 1.08B | -1.35% | 155,737 | - |
| 363 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.07B | 6.77% | 248,564 | 730.02M |
| 364 | MLTX | MoonLake Immunotherapeutics | 1.07B | 1.45% | 506,465 | - |
| 365 | CSTL | Castle Biosciences, Inc. | 1.06B | -1.64% | 114,806 | 357.28M |
| 366 | PRCT | PROCEPT BioRobotics Corporation | 1.06B | -3.94% | 381,266 | 337.34M |
| 367 | IRMD | IRADIMED CORPORATION | 1.06B | 0.84% | 49,473 | 86.34M |
| 368 | JBIO | Jade Biosciences, Inc. | 1.05B | -2.36% | 215,246 | - |
| 369 | LMRI | Lumexa Imaging Holdings, Inc. | 1.04B | -1.99% | 145,998 | 1.04B |
| 370 | CRVS | Corvus Pharmaceuticals, Inc. | 1.04B | -1.75% | 451,304 | - |
| 371 | GLUE | Monte Rosa Therapeutics, Inc. | 1.03B | - | 481,162 | 28.73M |
| 372 | JANX | Janux Therapeutics, Inc. | 1.03B | 1.66% | 260,854 | 24.00M |
| 373 | ANL | Adlai Nortye Group Ltd. | 1.03B | 1.72% | 35,547 | 18.06M |
| 374 | KURA | Kura Oncology, Inc. | 1.03B | -1.32% | 735,030 | 77.23M |
| 375 | STAA | STAAR Surgical Company | 1.02B | -2.16% | 355,896 | 339.59M |
| 376 | ENOV | Enovis Corporation | 1.01B | -2.44% | 532,108 | 2.30B |
| 377 | HELP | Cybin Inc. | 996.54M | 10.27% | 1,872,096 | - |
| 378 | ALMS | Alumis Inc. | 994.71M | -1.09% | 1,091,441 | 7.40M |
| 379 | ABUS | Arbutus Biopharma Corporation | 994.19M | 0.30% | 1,065,911 | 181.72M |
| 380 | SLBT | SL Science Holding Limited | 984.17M | 0.34% | 47,460 | 3.27M |
| 381 | APMD | Apnimed, Inc. | 979.99M | -18.83% | 460,718 | 115.12M |
| 382 | PCRX | Pacira BioSciences, Inc. | 971.63M | -1.28% | 103,594 | 746.16M |
| 383 | ATTO | Attovia Therapeutics, Inc. | 946.35M | -6.37% | 89,600 | 1.80M |
| 384 | SGP | SpyGlass Pharma, Inc. | 938.55M | -3.51% | 62,465 | - |
| 385 | CBLL | CeriBell, Inc. | 927.79M | -0.80% | 120,392 | 101.96M |
| 386 | GMRS | GMR Solutions Inc. | 920.23M | -5.51% | 325,451 | 5.88B |
| 387 | SLDB | Solid Biosciences Inc. | 919.99M | -3.70% | 521,902 | - |
| 388 | SANA | Sana Biotechnology, Inc. | 914.55M | -1.45% | 1,011,606 | - |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 909.93M | -0.24% | 754,277 | 41.47M |
| 390 | TBPH | Theravance Biopharma, Inc. | 885.21M | 0.18% | 296,936 | 104.31M |
| 391 | HSTM | HealthStream, Inc. | 882.88M | -1.28% | 50,688 | 321.12M |
| 392 | IMMX | Immix Biopharma, Inc. | 879.93M | -1.60% | 687,272 | - |
| 393 | IVA | Inventiva S.A. | 875.21M | -4.63% | 618,124 | 7.94M |
| 394 | RIGL | Rigel Pharmaceuticals, Inc. | 872.54M | 0.15% | 65,904 | 276.79M |
| 395 | ETRA | Electra Therapeutics, Inc. | 864.30M | 3.92% | 372,735 | - |
| 396 | ARDX | Ardelyx, Inc. | 862.19M | 1.17% | 959,632 | 450.89M |
| 397 | AVTX | Avalo Therapeutics, Inc. | 858.62M | -3.38% | 190,091 | 59.00K |
| 398 | CADL | Candel Therapeutics, Inc. | 857.01M | 3.23% | 551,084 | - |
| 399 | OLMA | Olema Pharmaceuticals, Inc. | 855.73M | -0.41% | 494,025 | - |
| 400 | FTH | Faeth Therapeutics, Inc. | 841.88M | -5.57% | 120,979 | - |
| 401 | WVE | Wave Life Sciences, Inc. | 837.45M | -2.30% | 988,945 | 65.37M |
| 402 | INMD | InMode Ltd. | 828.30M | 0.42% | 144,155 | 374.63M |
| 403 | GERN | Geron Corporation | 825.58M | -1.15% | 2,229,975 | 204.56M |
| 404 | ACHV | Achieve Life Sciences, Inc. | 814.99M | -0.75% | 336,176 | - |
| 405 | ACRS | Aclaris Therapeutics, Inc. | 814.75M | 0.64% | 666,419 | 8.22M |
| 406 | FDMT | 4D Molecular Therapeutics, Inc. | 812.09M | -3.42% | 280,817 | 92.01M |
| 407 | SIBN | SI-BONE, Inc. | 807.63M | -0.39% | 307,511 | 213.60M |
| 408 | AVR | Anteris Technologies Global Corp. | 789.41M | -0.74% | 369,862 | 2.24M |
| 409 | CLYM | Climb Bio, Inc. | 788.31M | -2.31% | 596,871 | - |
| 410 | ANNX | Annexon, Inc. | 785.81M | -2.01% | 1,851,476 | - |
| 411 | BLSM | BlossomHill Therapeutics, Inc. | 782.95M | -0.74% | 123,768 | - |
| 412 | VREX | Varex Imaging Corporation | 779.74M | 0.05% | 109,842 | 865.00M |
| 413 | AHCO | AdaptHealth Corp. | 775.77M | 1.84% | 755,739 | 3.36B |
| 414 | DSGN | Design Therapeutics, Inc. | 774.14M | 1.06% | 183,443 | - |
| 415 | GYRE | Gyre Therapeutics, Inc. | 765.56M | -4.37% | 91,758 | 109.82M |
| 416 | COLL | Collegium Pharmaceutical, Inc. | 747.15M | 0.79% | 353,751 | 808.21M |
| 417 | PHAR | Pharming Group N.V. | 744.14M | 3.32% | 148,394 | 366.48M |
| 418 | QDEL | QuidelOrtho Corporation | 739.93M | 1.60% | 352,343 | 2.67B |
| 419 | GLAS | Glass House Brands Inc. | 739.80M | -1.51% | 306,009 | 176.98M |
| 420 | SLN | Silence Therapeutics plc | 739.37M | 0.66% | 184,573 | 615.00K |
| 421 | DBVT | DBV Technologies S.A. | 729.61M | -2.75% | 69,600 | 5.04M |
| 422 | IRWD | Ironwood Pharmaceuticals, Inc. | 727.88M | 1.03% | 1,122,986 | 389.32M |
| 423 | NVCT | Nuvectis Pharma, Inc. | 712.23M | -0.64% | 47,756 | - |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 700.73M | 1.64% | 295,304 | 136.07M |
| 425 | VSTM | Verastem, Inc. | 695.53M | 3.23% | 885,211 | 87.53M |
| 426 | MDXG | MiMedx Group, Inc. | 693.82M | -0.21% | 399,892 | 355.17M |
| 427 | SOPH | SOPHiA GENETICS SA | 692.94M | -0.61% | 222,751 | 86.17M |
| 428 | STLN | Starling Oncology, Inc. | 689.97M | -2.73% | 531,001 | 587.24M |
| 429 | CTKB | Cytek Biosciences, Inc. | 685.01M | -0.57% | 261,810 | 206.71M |
| 430 | CBIO | Crescent Biopharma, Inc. | 680.11M | -5.92% | 195,346 | 11.88M |
| 431 | SGMT | Sagimet Biosciences Inc. | 673.80M | -2.25% | 290,926 | - |
| 432 | SSII | SS Innovations International, Inc. | 661.27M | 1.23% | 61,903 | 52.40M |
| 433 | OABI | OmniAb, Inc. | 660.07M | 1.57% | 474,909 | 38.46M |
| 434 | AURA | Aura Biosciences, Inc. | 655.41M | -1.86% | 282,818 | - |
| 435 | MNPR | Monopar Therapeutics Inc. | 647.19M | -0.05% | 43,429 | - |
| 436 | AHG | Akso Health Group | 646.81M | 0.49% | 1,955 | 13.83M |
| 437 | NGNE | Neurogene Inc. | 635.76M | -1.00% | 143,332 | 925.00K |
| 438 | ALT | Altimmune, Inc. | 634.13M | 0.31% | 2,179,947 | 31.00K |
| 439 | ANGO | AngioDynamics, Inc. | 625.77M | -1.94% | 97,847 | 320.17M |
| 440 | OCS | Oculis Holding AG | 621.02M | -0.79% | 91,213 | 1.45M |
| 441 | VALN | Valneva SE | 620.56M | 1.24% | 13,541 | 163.30M |
| 442 | PHR | Phreesia, Inc. | 617.61M | -0.90% | 299,846 | 507.79M |
| 443 | STTK | Shattuck Labs, Inc. | 613.22M | 1.66% | 542,613 | 1.00M |
| 444 | MPLT | MapLight Therapeutics, Inc. | 609.39M | 0.41% | 223,622 | - |
| 445 | CTMX | CytomX Therapeutics, Inc. | 607.94M | 1.09% | 829,193 | 18.30M |
| 446 | CRMD | CorMedix Inc. | 606.41M | 0.78% | 239,981 | 462.25M |
| 447 | DRUG | Bright Minds Biosciences Inc. | 602.76M | -0.48% | 44,965 | - |
| 448 | AQST | Aquestive Therapeutics, Inc. | 597.44M | 3.25% | 938,035 | 54.09M |
| 449 | EVO | Evotec SE | 593.99M | -3.75% | 293,539 | 819.47M |
| 450 | PHAT | Phathom Pharmaceuticals, Inc. | 589.37M | -0.80% | 445,197 | 239.66M |
| 451 | WEAV | Weave Communications, Inc. | 586.79M | 0.62% | 708,011 | 257.79M |
| 452 | FLGT | Fulgent Genetics, Inc. | 583.05M | -2.31% | 107,480 | 323.93M |
| 453 | KIDS | OrthoPediatrics Corp. | 576.77M | 1.24% | 86,206 | 252.72M |
| 454 | ALLO | Allogene Therapeutics, Inc. | 571.79M | -2.07% | 2,209,335 | 4.64M |
| 455 | EPRX | Eupraxia Pharmaceuticals Inc. | 563.16M | 0.70% | 149,541 | - |
| 456 | AGMB | AgomAb Therapeutics NV | 562.90M | -6.08% | 56,667 | - |
| 457 | TLRY | Tilray Brands, Inc. | 558.93M | 2.26% | 2,432,832 | 915.45M |
| 458 | PRME | Prime Medicine, Inc. | 557.73M | 0.48% | 1,711,739 | 4.07M |
| 459 | DCTH | Delcath Systems, Inc. | 553.97M | -0.90% | 118,435 | 95.42M |
| 460 | BWAY | BrainsWay Ltd. | 543.39M | -1.10% | 29,279 | 60.70M |
| 461 | ARVN | Arvinas, Inc. | 540.09M | -0.36% | 231,387 | 316.70M |
| 462 | DNA | Ginkgo Bioworks Holdings, Inc. | 539.40M | 1.65% | 1,107,478 | 132.42M |
| 463 | PROK | ProKidney Corp. | 538.13M | -6.81% | 656,488 | 818.00K |
| 464 | CAPR | Capricor Therapeutics, Inc. | 530.23M | 0.66% | 1,170,983 | 11.13M |
| 465 | CERS | Cerus Corporation | 525.98M | -1.51% | 981,892 | 221.55M |
| 466 | SCTX | Scribe Therapeutics Inc. | 525.16M | -15.94% | 292,269 | 33.30M |
| 467 | OVID | Ovid Therapeutics Inc. | 523.40M | -0.37% | 496,140 | 1.58M |
| 468 | EOLS | Evolus, Inc. | 522.46M | 0.64% | 157,791 | 316.49M |
| 469 | ASMB | Assembly Biosciences, Inc. | 521.94M | 2.66% | 74,484 | 74.85M |
| 470 | TECX | Tectonic Therapeutic, Inc. | 520.40M | -1.41% | 50,552 | - |
| 471 | RGNX | REGENXBIO Inc. | 517.54M | -2.37% | 468,332 | 174.48M |
| 472 | CTNM | Contineum Therapeutics, Inc. | 515.41M | 1.26% | 192,830 | - |
| 473 | AUTL | Autolus Therapeutics plc | 515.02M | -0.26% | 305,710 | 117.39M |
| 474 | TCMD | Tactile Systems Technology, Inc. | 512.62M | 1.94% | 71,476 | 350.31M |
| 475 | ENTX | Entera Bio Ltd. | 512.50M | - | 130,234 | 42.00K |
| 476 | CTEV | Claritev Corporation | 511.22M | -2.09% | 57,582 | 994.67M |
| 477 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 478 | KMDA | Kamada Ltd. | 501.36M | -0.73% | 64,483 | 191.85M |
| 479 | SENS | Senseonics Holdings, Inc. | 500.19M | -1.25% | 302,610 | 48.55M |
| 480 | NPCE | NeuroPace, Inc. | 495.81M | 1.16% | 21,827 | 106.99M |
| 481 | PBYI | Puma Biotechnology, Inc. | 494.52M | -0.21% | 102,628 | 231.24M |
| 482 | PRLD | Prelude Therapeutics Incorporated | 485.11M | -3.29% | 183,171 | 22.42M |
| 483 | NRC | NRC Health | 479.77M | 5.50% | 35,653 | 140.00M |
| 484 | SRTA | Strata Critical Medical, Inc. | 478.61M | 1.31% | 236,336 | 255.98M |
| 485 | EIKN | Eikon Therapeutics, Inc. | 473.94M | -2.23% | 211,931 | - |
| 486 | SGHT | Sight Sciences, Inc. | 449.52M | 1.75% | 46,870 | 83.38M |
| 487 | MASS | 908 Devices Inc. | 448.47M | 3.04% | 121,757 | 60.84M |
| 488 | IRD | Opus Genetics, Inc. | 445.93M | 3.47% | 983,567 | 9.86M |
| 489 | ARCT | Arcturus Therapeutics Holdings Inc. | 441.69M | -3.06% | 316,676 | 29.37M |
| 490 | PRTA | Prothena Corporation plc | 437.90M | -0.58% | 117,164 | 54.53M |
| 491 | RLMD | Relmada Therapeutics, Inc. | 437.88M | -0.36% | 217,423 | - |
| 492 | TKNO | Alpha Teknova, Inc. | 437.02M | 4.49% | 230,758 | 43.70M |
| 493 | EDIT | Editas Medicine, Inc. | 436.17M | 5.19% | 1,209,306 | 47.01M |
| 494 | KYTX | Kyverna Therapeutics, Inc. | 436.00M | -1.12% | 359,363 | - |
| 495 | SPRY | ARS Pharmaceuticals, Inc. | 434.58M | 6.33% | 490,166 | 116.93M |
| 496 | VOGX | Vogenx, Inc. | 432.43M | -10.43% | 173,361 | - |
| 497 | INDP | Indaptus Therapeutics, Inc. | 431.88M | -8.70% | 339,240 | - |
| 498 | AVIR | Atea Pharmaceuticals, Inc. | 431.50M | 0.94% | 95,147 | - |
| 499 | CLPT | ClearPoint Neuro, Inc. | 428.58M | 1.59% | 181,879 | 42.28M |
| 500 | TTRX | Turn Therapeutics Inc. | 427.76M | -3.88% | 77,608 | - |